Nath Bio-Genes submitted audio recording of its conference call held on 05th May 2026 to discuss audited financial results for Q4 and FY ended 31st March 2026.
The submission was made in compliance with SEBI Listing Regulations (Regulation 30 read with Schedule III).
The audio recording is available on the company's website at a provided specific link.